Canine CA50 antibody and antigen (recombinant protein)
Diagnostic anti-Canine CA50 antibodies pairs and antigen for animal health (animal Dog/Canine pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-CA50-Ag01 | Canine CA50 | $3090.00 |
GMP-CAN-CA50-Ab01 | Anti-Canine CA50 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-CA50-Ab02 | Anti-Canine CA50 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-CA50-Ab03 | Anti-Canine CA50 human monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-CA50-Ab04 | Anti-Canine CA50 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-CAN-CA50-Ag01 |
Product Name | Canine CA50 |
Target/Biomarker | Canine CA50 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine CA50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Tag | His | Reconized/Reactive Specics | Canine CA50 |
Product description | Recombinant Canine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-CA50-Ab01,GMP-CAN-CA50-Ab02 |
Target/Biomarker | Canine CA50 |
Product Name | Anti-Canine CA50 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies in Canine CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Product description | Anti-Canine CA50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-CA50-Ab03,GMP-CAN-CA50-Ab04 |
Target/Biomarker | Canine CA50 |
Product Name | Anti-Canine CA50 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Canine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies in Canine CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer. |
Product description | Anti-Canine CA50 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in canine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in dogs, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules.
In the context of canine health, CA50 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA50 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes.
CA50 levels in a dog's bloodstream become elevated when cancer cells, particularly those found in gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA50 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.